Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Davita Healthcare Partners Inc (DVA)

Davita Healthcare Partners Inc (DVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,107,098
  • Shares Outstanding, K 121,989
  • Annual Sales, $ 11,388 M
  • Annual Income, $ 810,980 K
  • 60-Month Beta 1.18
  • Price/Sales 0.97
  • Price/Cash Flow 8.04
  • Price/Book 4.74
Trade DVA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 1.49
  • Number of Estimates 7
  • High Estimate 1.63
  • Low Estimate 1.26
  • Prior Year 1.53
  • Growth Rate Est. (year over year) -2.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
80.85 +12.62%
on 10/01/20
91.70 -0.71%
on 10/16/20
+8.64 (+10.48%)
since 09/23/20
3-Month
80.85 +12.62%
on 10/01/20
92.67 -1.75%
on 09/16/20
+3.37 (+3.84%)
since 07/23/20
52-Week
56.99 +59.76%
on 10/25/19
92.67 -1.75%
on 09/16/20
+31.93 (+54.01%)
since 10/23/19

Most Recent Stories

More News
Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?

Is (DVA) Outperforming Other Medical Stocks This Year?

DVA : 91.05 (+0.41%)
DaVita Clinical Research to Present New Findings at American Society of Nephrology Kidney Week 2020

, /PRNewswire/ -- DaVita Clinical Research (DCR) will present 14 research abstracts from company representatives and medical professionals at the American Society of Nephrology (ASN) annual occurring...

DVA : 91.05 (+0.41%)
DVA vs. CHE: Which Stock Should Value Investors Buy Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

DVA : 91.05 (+0.41%)
CHE : 488.64 (+0.08%)
Higher Testing Volume to Aid LabCorp's (LH) Q3 Earnings

In Q3, LabCorp (LH) significantly expands accessibility of PCR testing to reach underserved communities.

DVA : 91.05 (+0.41%)
HUM : 444.31 (+0.71%)
LH : 207.49 (+1.09%)
LHCG : 216.91 (-1.00%)
Baxter Supports Findings of Ongoing COVID-19 Nutrition Study

The study, supported by Baxter (BAX) through an investigator-initiated grant, is the first analysis of longitudinal REE in critically ill, mechanically-ventilated COVID-19 patients.

BAX : 81.09 (-0.44%)
DVA : 91.05 (+0.41%)
BSX : 37.17 (+0.84%)
TMO : 480.17 (-0.38%)
Here's Why You Should Invest in AmerisourceBergen (ABC) Now

AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.

DVA : 91.05 (+0.41%)
ABC : 99.38 (+0.67%)
BSX : 37.17 (+0.84%)
TMO : 480.17 (-0.38%)
LHC Group (LHCG) and CHRISTUS Health Extend JV Partnership

LHC Group (LHCG) and CHRISTUS Health expand their partnership to boost home health services and hospice care.

DVA : 91.05 (+0.41%)
BSX : 37.17 (+0.84%)
TMO : 480.17 (-0.38%)
LHCG : 216.91 (-1.00%)
Here's Why You Should Retain Accuray (ARAY) Stock for Now

Investors' confidence is high in the Accuray (ARAY) stock, thanks to its solid prospects.

ARAY : 3.10 (-0.96%)
DVA : 91.05 (+0.41%)
BSX : 37.17 (+0.84%)
TMO : 480.17 (-0.38%)
Here's Why You Should Retain AMN Healthcare (AMN) Stock Now

AMN Healthcare (AMN) continues to gain traction from its wide range of services, and Healthcare MSP. Intense competition remains a woe.

DVA : 91.05 (+0.41%)
BSX : 37.17 (+0.84%)
TMO : 480.17 (-0.38%)
AMN : 66.51 (+0.18%)
Allscripts Completes Sale of EPSi Business to Strata

Allscripts (MDRX) completes the sale of its EPSi business to Strata. Notably, the combination of two companies can reduce cost associated with healthcare.

MDRX : 10.92 (-2.76%)
DVA : 91.05 (+0.41%)
BSX : 37.17 (+0.84%)
TMO : 480.17 (-0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

DaVita Inc. is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney Care is a provider of kidney care, delivering dialysis services for chronic kidney failure and end stage renal disease primarily in the United States. HealthCare Partners manages and operates medical groups...

See More

Key Turning Points

2nd Resistance Point 92.27
1st Resistance Point 91.66
Last Price 91.05
1st Support Level 90.40
2nd Support Level 89.76

See More

52-Week High 92.67
Last Price 91.05
Fibonacci 61.8% 79.04
Fibonacci 50% 74.83
Fibonacci 38.2% 70.62
52-Week Low 56.99

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar